Schisandra chinensis lignans improve insulin resistance by targeting TLR4 and activating IRS-1/PI3K/AKT and NF-κB signaling pathways.
Schisandra chinensis compounds 2 and 4 improve insulin resistance by targeting TLR4, modulating NF-κB and IRS-1/PI3K/AKT pathways, offering potential as T2DM treatments.
- Zhao SL et al (2024).
- Int Immunopharmacol.
- PubMed:
- 39241520